133 related articles for article (PubMed ID: 37649920)
1. The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
McMullan JC; Rainey L; Morgan D; Johnston L
Ulster Med J; 2023 May; 92(2):84-88. PubMed ID: 37649920
[TBL] [Abstract][Full Text] [Related]
2. Cervical screening: management of patients referred for colposcopy with smear abnormalities less severe than dyskaryosis.
Usman F; Hammond R
Cytopathology; 1998 Apr; 9(2):100-6. PubMed ID: 9577736
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. The impact of the CervicalCheck controversy on provision of colposcopy services in Ireland: A cohort study.
Cheung M; Fitzpatrick M
Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():228-231. PubMed ID: 34087721
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years.
Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE
Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660
[TBL] [Abstract][Full Text] [Related]
6. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
7. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
8. Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
Leeson S; Evered A; Powell G; Lilly K; Singh N; Hillier S; Dunk L
Cytopathology; 2022 May; 33(3):350-356. PubMed ID: 34935223
[TBL] [Abstract][Full Text] [Related]
9. Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme.
MacArthur GJ; Wright M; Beer H; Paranjothy S
J Med Screen; 2011; 18(4):204-9. PubMed ID: 22156146
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of cervical screening in women under 25 years (2005-2009).
Ali AA; Richardson D; Hill N
Arch Gynecol Obstet; 2013 Apr; 287(4):765-9. PubMed ID: 23183714
[TBL] [Abstract][Full Text] [Related]
11. Should patients with mild atypia in a cervical smear be referred for colposcopy?
Soutter WP; Wisdom S; Brough AK; Monaghan JM
Br J Obstet Gynaecol; 1986 Jan; 93(1):70-4. PubMed ID: 3942709
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
13. Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.
Masson H
Womens Health (Lond); 2021; 17():17455065211017070. PubMed ID: 34032158
[TBL] [Abstract][Full Text] [Related]
14. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
15. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation.
Peron M; Llewellyn A; Moe-Byrne T; Walker S; Walton M; Harden M; Palmer S; Simmonds M
Health Technol Assess; 2018 Sep; 22(54):1-260. PubMed ID: 30284968
[TBL] [Abstract][Full Text] [Related]
17. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
18. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
19. Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?
Caeiro V; Nunes S; Esteves B; Moutinho-Fonseca J
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1907-1912. PubMed ID: 34181350
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
